Prapti Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Prapti Patel has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Robert H. Collins
Department of Internal Medicine University of Texas Southwestern Medical Center 75390 Dallas TX USA
12 shared publications - Stephen S. Chung
Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
12 shared publications - Weina Chen
Department of Pathology University of Texas Southwestern Medical Center Dallas Texas USA
12 shared publications - Yazan F. Madanat
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, USA
12 shared publications - Alice S. Mims
The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
11 shared publications - Amy Burd
The Leukemia & Lymphoma Society 10573 Rye Brook NY USA
11 shared publications
Latest Publications
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Supplementary Data from Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance